Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Sundan

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
The FEBS Journal|December 20, 2015
A-kinase anchoring protein AKAP95 is a novel regulator of ribosomal RNA synthesisAnne Marstad, Ole Jørgen B Landsverk, Olaf Strømme, et al.
Haematologica|April 12, 2005
Human myeloma cells adhere to fibronectin in response to hepatocyte growth factorRandi Utne Holt, Vadim Baykov, Torstein Baade Rø, et al.
Experimental Cell Research|July 9, 2019
Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cellsOlaf Strømme, Katarzyna M Psonka-Antonczyk, Bjørn Torger Stokke, et al.
European Journal of Haematology|July 23, 2013
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunateToril Holien, Oddrun E Olsen, Kristine Misund, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
Cancer Letters|March 5, 2013
Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathwayVirginie Follin-Arbelet, Maria Lyngaas Torgersen, Elin Hallan Naderi, et al.
The New England Journal of Medicine|March 8, 2018
A Gain-of-Function Mutation in EPO in Familial ErythrocytosisJakub Zmajkovic, Pontus Lundberg, Ronny Nienhold, et al.
Blood|September 28, 2002
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cellsTherese Standal, Carina Seidel, Øyvind Hjertner, et al.
Plos One|October 8, 2015
PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 TherapyAnne-Marit Sponaas, Neda Nejati Moharrami, Emadoldin Feyzi, et al.
The Journal of Biological Chemistry|June 11, 2004
Lipopolysaccharide and double-stranded RNA up-regulate toll-like receptor 2 independently of myeloid differentiation factor 88Nadra Nilsen, Unni Nonstad, Naseema Khan, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
The FEBS Journal|December 20, 2015
A-kinase anchoring protein AKAP95 is a novel regulator of ribosomal RNA synthesisAnne Marstad, Ole Jørgen B Landsverk, Olaf Strømme, et al.
Haematologica|April 12, 2005
Human myeloma cells adhere to fibronectin in response to hepatocyte growth factorRandi Utne Holt, Vadim Baykov, Torstein Baade Rø, et al.
Experimental Cell Research|July 9, 2019
Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cellsOlaf Strømme, Katarzyna M Psonka-Antonczyk, Bjørn Torger Stokke, et al.
European Journal of Haematology|July 23, 2013
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunateToril Holien, Oddrun E Olsen, Kristine Misund, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
Cancer Letters|March 5, 2013
Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathwayVirginie Follin-Arbelet, Maria Lyngaas Torgersen, Elin Hallan Naderi, et al.
The New England Journal of Medicine|March 8, 2018
A Gain-of-Function Mutation in EPO in Familial ErythrocytosisJakub Zmajkovic, Pontus Lundberg, Ronny Nienhold, et al.
Blood|September 28, 2002
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cellsTherese Standal, Carina Seidel, Øyvind Hjertner, et al.
Plos One|October 8, 2015
PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 TherapyAnne-Marit Sponaas, Neda Nejati Moharrami, Emadoldin Feyzi, et al.
The Journal of Biological Chemistry|June 11, 2004
Lipopolysaccharide and double-stranded RNA up-regulate toll-like receptor 2 independently of myeloid differentiation factor 88Nadra Nilsen, Unni Nonstad, Naseema Khan, et al.
Pageof 8